Intravenous Immunoglobulin in Prevention of Preterm Neonatal Sepsis

Summary

Majority of healthcare authorities believe that due to the methodological weakness and small number of patients in conducted therapeutic trials, the evidences are insufficient to support the efficacy of intravenous immunoglobulin (IVIG) in prevention of preterm neonatal sepsis. The objective of this research is to determine the effect of intravenous immunoglobulin in prevention of preterm neonatal sepsis.

Timeline

Start

2015-11

Primary completion

2016-10

Completion

2016-11

Drugs

Indications